#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Malignant peritoneal neoplasm Myeloid leukaemia Non-Hodgkin's lymphoma refractory Ewing's sarcoma metastatic Kidney transplant rejection Epstein-Barr virus infection Extraskeletal ossification Leiomyosarcoma metastatic Neurodermatitis Trigeminal neuralgia Renal cell carcinoma Urea cycle disorder Antisynthetase syndrome Liposarcoma metastatic Penile cancer More trials…

    Learn about Rare Diseases

    Haemophilia A without inhibitors – Diagnostics Haemophilia B without inhibitors – Basic Information Primary mediastinal large B-cell lymphoma – Diagnostics Malignant fibrous histiocytoma – Life with Disease Choroid melanoma – Life with Disease Leiomyosarcoma – Trials in Disease Basal cell naevus syndrome – Life with Disease Glycogen storage disease type I Mantle cell lymphoma refractory – Trials in Disease Paroxysmal nocturnal haemoglobinuria – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sacubitril Odronextamab Tiratricol Clazakizumab [18F]CPFPX Diphenhydramine Cellulose, Microcrystalline Peppermint Oil Patiromer Paracetamol Dc Riliprubart Magnesium Oxide, Light Dimethyl Fumarate Incb000928 Autogene Cevumeran Ro7269162 Arachis Hypogaea Extract Lysine Acetate SARACATINIB Gedatolisib More therapies…

    Learn about Your Condition

    Prinzmetal angina Seasonal allergy Peripheral spondyloarthritis Lung transplant Deafness Congenital myopathy Multiple system atrophy Left ventricular failure Retinoblastoma Fungal infection Tinnitus Hypoxia Kidney transplant rejection Primary hypogonadism Ulcerative keratitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Study of N-Acetyl-GED-0507-34-LEVO 5% gel applied daily for 12 weeks in patients with acne vulgaris

    Not recruiting

    3 1
    Investigated Drugs:
    • (S)-3-(4-Acetamidophenyl)-2-Methoxypropanoic Acid
    Italy Poland Spain

  • Study on the Safety of Mogamulizumab for Patients with Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Cutaneous T-cell lymphoma recurrent
    Investigated Drugs:
    • Mogamulizumab
    France Spain

  • Title: Long-term safety study of N-Acetyl-GED-0507-34-LEVO gel 5% applied to the skin for patients with acne vulgaris

    Not recruiting

    3 1 1
    Investigated Drugs:
    • (S)-3-(4-Acetamidophenyl)-2-Methoxypropanoic Acid
    Italy Poland Spain

  • Study on Tralokinumab and Topical Corticosteroids for Children and Infants with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    4 1 1
    Investigated Drugs:
    • Tralokinumab
    Belgium Croatia Czechia Denmark Germany Ireland +6

  • Study on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Barzolvolimab
    • Epinephrine
    Belgium Bulgaria Czechia Denmark France Germany +5

  • Study of Lutikizumab compared to placebo in adults and adolescents (age 12 and older) with moderate to severe Hidradenitis Suppurativa

    Not recruiting

    3 1
    Investigated Drugs:
    • Lutikizumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +16
Previous Page
1 … 44 45 46 47 48 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!